Navigation Links
Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae

ratory band 11, which is a doublet, is partially resolved in UCD 522A. The laboratory form of band 12 (chromosome IV) is not present. Instead, a faster- migrating band is seen which just merges with the partially resolved doublet corresponding to laboratory band 11. The karyotype of the genetically purified and presumably homozygous clone 522XA (lane D) has a different profile than its progenitor, UCD 522A. The band migrating just ahead of laboratory band 3 is absent while laboratory doublet band 11, partially resolved in UCD 522A, is completely resolved.

The profile of UCD 505K (lane E) indicated the presence of laboratory band 3, the faster migrating band seen in the UCD 522A profile, and a unique band migrating between laboratory bands 4 and 5. The faster migrating form of laboratory band 7 seen in UCD 522A and 522XA has a diffuse counterpart in UCD 505K profile. Laboratory bands 10, 11, and 13 have approximate counterparts in UCD 505K, but band 12 is absent.

The profile of UCD 595A (lane F) indicated a very faint counterpart to laboratory band 1, perhaps three merged bands migrating between laboratory bands 2 and 3, and a partially resolved doublet corresponding to laboratory band 5. Laboratory bands 6 through 9 have diffuse and approximate counterparts in this wine strain which may indicate the presence of additional and unresolved chromosomes. As in UCD 505K, laboratory bands 10, 11, and 13 have counterparts in this strain, while band 12 is absent. Instead, a faint band migrates slightly more slowly than the UCD 595A form of laboratory band 11.

While the electrophoretic profiles of UCD 522A, UCD 505K, and UCD 595A provide qualitative evidence for aneuploidy, a more useful qu
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. DNA/RNA Blotting With the Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell
2. Separation and Comparison of Proteins From Virulent and Nonvirulent Strains of the Fish Pathogen Flavobacterium psychrophilum, Using a 2-D Electrophoretic Approach
3. Saccharomyces cerevisiae
4. Saccharomyces cerevisiae
5. Saccharomyces cerevisiae
6. Saccharomyces cerevisiae
7. Cytosolic expression of Green Fluorescent Protein (GFP) and its derivatives in the yeast Saccharomyces cerevisiae: Detection in vivo using the Varian Cary Eclipse
8. Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse

Post Your Comments:
(Date:11/24/2009)...alth care employment grew by 29,000 jobs in Octob...sistent growth during the U.S. recession. However,..., and health systems are coming closer to having t...administrators. , (Vocus)...nued growing in October despite the shedding of jo...
(Date:11/24/2009)..., Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy an...ration (SFDA) has approved the,investigational new...ct,(Nodlin), an innovative insulin formulation to ...o initiate its first phase I clinical study. ,,...h blood glucose and poor,metabolism. The complicat...
(Date:11/24/2009)... , TORONTO, Nov. 24 /PRNewswire-FirstCall/ - ...o Capital Inc., a leading provider of advanced las...rch and fertility clinic markets, today reported o...rter ended September 30, 2009. , , Q3 2009 Hig...d with $1.43 million in Q3 2008, - Gross prof...
(Date:11/24/2009)...ly, November 24 Health Robotics to...int venture with a group of selected,investors. Th...ate under the,name Health Robotics Canada, Inc. an...s, i.v. Room of the Future concept, which includes...M), i.v.SOFT(TM), and OMM(TM).,Health Robotics Can...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
...ourt made a patent-law decision on Monday that cou...nt holders in the biotechnology sector. , ,The cou... Searle & Co. This effectively solidifies the dec...or the Federal Circuit, which invalidated a biotec...dequate written description of the invention. , ,...
... 2006, Wisconsin will no longer be allowed to tax ...gs for users but could put a hole in the state bud...as authored by Representative James Sensenbrenner... dollar a month. , ,It was inserted into the Inter... that exempts all Internet access from taxes. Legi...
...nic Foundry Inc. increased sales of its media pro..., up from $1.3 million last year, the company said...verall loss this year of $5.4 million. Last year, ...ion sale of discontinued business units led to a p...product is Mediasite Live , a presentation system...
Other Biology Technology:Describe your invention, or your biotech patent may be worthless 2Describe your invention, or your biotech patent may be worthless 3Describe your invention, or your biotech patent may be worthless 4Describe your invention, or your biotech patent may be worthless 5State faces revenue drop as federal Internet tax ban passes House 2
(Date:11/25/2009)...University assistant professors recently received ... to continue research beneficial to understanding ..., Christopher Blackwood, assistant professor in ... grants to support two separate research projects....Decomposer Communities and Functions from the Leaf...
(Date:11/24/2009)...f years it has been prescribed by traditional heal...adaches and stomach pain to fever and flu. , Now ...rsity have been able to scientifically prove the p...rwise known as Brazilian mint. , Testing this anc...researcher Graciela Rocha was able to show that wh...
(Date:11/24/2009)...is opening new doors to understanding how sounds a... of a marine mammal or if they hear it at all. ,...anners that NASA uses to detect flaws in the space...wing scientists to peek inside the giant head of a...ensional replicas of a whale,s hearing anatomy usi...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 1CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 2CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 3CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 4CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 5CareTech Expands Relationship With Marietta Memorial Hospital With Five Year Total IT Services Management Agreement 56535 1CareTech Expands Relationship With Marietta Memorial Hospital With Five Year Total IT Services Management Agreement 56535 2CareTech Expands Relationship With Marietta Memorial Hospital With Five Year Total IT Services Management Agreement 56535 3Wilmington Pharmaceuticals Receives FDA Approval for Orally Disintegrating Metoclopramide Tablet 13932 1Wilmington Pharmaceuticals Receives FDA Approval for Orally Disintegrating Metoclopramide Tablet 13932 2Wilmington Pharmaceuticals Receives FDA Approval for Orally Disintegrating Metoclopramide Tablet 13932 3Wilmington Pharmaceuticals Receives FDA Approval for Orally Disintegrating Metoclopramide Tablet 13932 4
...A group of researchers from the LGC Chemical Metro...ersity of Oviedo, Spain, have come up with a metho...hemical element (atoms with an equal number of pro...ns) vary throughout the length of a single hair. T...ethods to track the geographical movements of peop...
... New Rochelle, NY, May 27, 2009New guidelines desi...eatment, and monitoring of patients with Medullary...ing form of thyroid cancer, have been developed by...line ahead of print in Thyroid , a peer-reviewed ...liebertpub.com ). The guidelines are available fre...
...The Society of Environmental Toxicology and Chemis...d to address the theme of "Protecting Ecosystem He...Environment," May 31 June 4 at the Gothenburg Con...ts on the environment, risks from new pharmaceutic...l, polar ecotoxicology, and the interaction of con...
Other Biology News:Sulphur in just one hair could blow a terrorist's alibi 2Sulphur in just one hair could blow a terrorist's alibi 3First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal 2SETAC Europe addresses global ecosystem health in Gothenburg 2
Donkey Serum from CHEMICON
acridine orange 10-nonyl bromide (nonyl acridine orange) from Molecular Probes (Invitrogen)
Mouse Anti-Rat RT1Bu (Class II Polymorphic) Monoclonal Antibody, Biotin Conjugated from AbD Serotec
GIBCO MEM Vitamin Solution (100X) liquid from Invitrogen
Biology Products: